M.J. van Gent

679 total citations
12 papers, 528 citations indexed

About

M.J. van Gent is a scholar working on Epidemiology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, M.J. van Gent has authored 12 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in M.J. van Gent's work include Herpesvirus Infections and Treatments (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). M.J. van Gent is often cited by papers focused on Herpesvirus Infections and Treatments (3 papers), T-cell and B-cell Immunology (3 papers) and Immune Cell Function and Interaction (3 papers). M.J. van Gent collaborates with scholars based in Netherlands, Canada and United Kingdom. M.J. van Gent's co-authors include René A. W. van Lier, Mireille T. M. Vossen, Taco W. Kuijpers, Paul A. Baars, Jan Weel, Jörg Hamann, Mourad Matmati, Jean‐Claude Davin, Kirsten M. L. Hertoghs and M.C.M. de Jong and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

M.J. van Gent

10 papers receiving 516 citations

Peers

M.J. van Gent
J Maciejewski United States
Jessica L. Pollock United States
T Shibuya Japan
F Niedobitek Germany
Pamela Mundt Germany
Katja Brandt Germany
Gill Ps United States
Gorin Nc France
Astrid Rascu Germany
J Maciejewski United States
M.J. van Gent
Citations per year, relative to M.J. van Gent M.J. van Gent (= 1×) peers J Maciejewski

Countries citing papers authored by M.J. van Gent

Since Specialization
Citations

This map shows the geographic impact of M.J. van Gent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. van Gent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. van Gent more than expected).

Fields of papers citing papers by M.J. van Gent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. van Gent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. van Gent. The network helps show where M.J. van Gent may publish in the future.

Co-authorship network of co-authors of M.J. van Gent

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. van Gent. A scholar is included among the top collaborators of M.J. van Gent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. van Gent. M.J. van Gent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vossen, Mireille T. M., Mourad Matmati, Kirsten M. L. Hertoghs, et al.. (2008). CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets. The Journal of Immunology. 180(6). 3739–3745. 145 indexed citations
2.
Vossen, Mireille T. M., M.J. van Gent, Pauline M. E. Wertheim‐van Dillen, et al.. (2005). Persistent Detection of Varicella-Zoster Virus DNA in a Previously Healthy Child after Severe Chickenpox. Journal of Clinical Microbiology. 43(11). 5614–5621. 7 indexed citations
3.
Vossen, Mireille T. M., M.J. van Gent, Jean‐Claude Davin, et al.. (2004). Spontaneous outgrowth of EBV-transformed B-cells reflects EBV-specific immunity in vivo; a useful tool in the follow-up of EBV-driven immunoproliferative disorders in allograft recipients. Transplant International. 17(2). 89–96. 5 indexed citations
4.
Vossen, Mireille T. M., M.J. van Gent, Jan Weel, et al.. (2004). Development of Virus‐Specific CD4+T Cells on Reexposure to Varicella‐Zoster Virus. The Journal of Infectious Diseases. 190(1). 72–82. 62 indexed citations
5.
Vossen, Mireille T. M., Maarten H. Biezeveld, M.C.M. de Jong, et al.. (2004). Absence of Circulating Natural Killer and Primed CD8+Cells in Life‐Threatening Varicella. The Journal of Infectious Diseases. 191(2). 198–206. 45 indexed citations
6.
Vossen, Mireille T. M., M.J. van Gent, Jean‐Claude Davin, et al.. (2004). Spontaneous outgrowth of EBV-transformed B-cells reflects EBV-specffic immunity in vivo; a useful tool in the follow-up of EBV-driven immunoproliferative disorders in allograft recipients. Transplant International. 17(2). 89–96. 2 indexed citations
7.
Kuijpers, Taco W., Mireille T. M. Vossen, M.J. van Gent, et al.. (2003). Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV. The Journal of Immunology. 170(8). 4342–4348. 134 indexed citations
8.
Gent, M.J. van, et al.. (1999). Een gezond bedrijf haalt ervaren talent uit de WAO : effectmeting campagne reïntegratie: onderzoek naar de significante verschillen in kennis, houding en gedrag van werkgevers ten aanzien van arbeidsgehandicpeten als effect door de campagne. TNO Repository. 1 indexed citations
9.
Adachi, Jonathan D., W. Bensen, Mary Bell, et al.. (1997). Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis. Lara D. Veeken. 36(2). 255–259. 75 indexed citations
10.
Faber, Dirk J., et al.. (1997). De rekeningen van de grafelijkheid van Holland uit de Beierse periode. Data Archiving and Networked Services (DANS).
11.
Levine, Mark N., et al.. (1991). When is a prognostic factor useful? A guide for the perplexed.. Journal of Clinical Oncology. 9(2). 348–356. 49 indexed citations
12.
Bürgi, H, et al.. (1968). ANTIBIOTICS IN SINUS SECRETIONS. The Lancet. 292(7564). 406–406. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026